| Source Date | Board Meeting Date | Details |
| 09 Feb 2026 | 12 Feb 2026 | Quarterly Results |
| 03 Nov 2025 | 07 Nov 2025 | Increase in Authorised Capital & Inter alia, to conduct and approve the following business: 1. To consider the increase in Authorized Share Capital of the Company and consequential amendment to the capital clause of MOA of Company; 2. To consider raising of funds, in one or more tranches, by issue of equity shares and/or any other instruments or eligible securities representing either equity shares and/or convertible securities linked to equity shares or through any other permissible mode or a combination thereof, by way of further public issue, right issues, ADRs/ GDRs/ FCCBs, debt issue, preferential allotment, private placement, QIP, or any other method as may be permitted under the applicable laws; 3. Notice of EOGM for seeking approval of Equity Shareholders in respect of increase of authorized share capital and raising of funds. |
| 20 Oct 2025 | 27 Oct 2025 | Quarterly Results |
| 14 Jul 2025 | 18 Jul 2025 | Quarterly Results |
| 27 May 2025 | 30 May 2025 | Audited Results & Quarterly Results |
| 04 Feb 2025 | 07 Feb 2025 | Quarterly Results & Interim Dividend |
| 08 Nov 2024 | 14 Nov 2024 | Quarterly Results |
